Clinical Trial Update: A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing pimozide in patients with amyotrophic lateral sclerosis (ALS) has been announced; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Pimozide (Pimozide)

Snippet

Sponsor: University of Calgary | Conditions: ALS, Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN